Estrogen and the skeleton
- PMID: 22595550
- PMCID: PMC3424385
- DOI: 10.1016/j.tem.2012.03.008
Estrogen and the skeleton
Abstract
Estrogen is the major hormonal regulator of bone metabolism in women and men. Therefore, there is considerable interest in unraveling the pathways by which estrogen exerts its protective effects on bone. Although the major consequence of the loss of estrogen is an increase in bone resorption, estrogen deficiency is associated with a gap between bone resorption and formation, indicating that estrogen is also important for maintaining bone formation at the cellular level. Direct estrogen effects on osteocytes, osteoclasts, and osteoblasts lead to inhibition of bone remodeling, decreased bone resorption, and maintenance of bone formation, respectively. Estrogen also modulates osteoblast/osteocyte and T-cell regulation of osteoclasts. Unraveling these pleiotropic effects of estrogen may lead to new approaches to prevent and treat osteoporosis.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.Int J Mol Sci. 2022 Jan 25;23(3):1376. doi: 10.3390/ijms23031376. Int J Mol Sci. 2022. PMID: 35163300 Free PMC article. Review.
-
Interleukin 7 and estrogen-induced bone loss.Trends Endocrinol Metab. 2003 May-Jun;14(4):147-9. doi: 10.1016/s1043-2760(03)00047-x. Trends Endocrinol Metab. 2003. PMID: 12714270 Review.
-
Obesity induces osteoimmunology imbalance: Molecular mechanisms and clinical implications.Biomed Pharmacother. 2024 Aug;177:117139. doi: 10.1016/j.biopha.2024.117139. Epub 2024 Jul 16. Biomed Pharmacother. 2024. PMID: 39018871 Review.
-
Osteocytes: The master cells in bone remodelling.Curr Opin Pharmacol. 2016 Jun;28:24-30. doi: 10.1016/j.coph.2016.02.003. Epub 2016 Feb 27. Curr Opin Pharmacol. 2016. PMID: 26927500 Review.
-
Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology.Front Immunol. 2024 May 16;15:1396122. doi: 10.3389/fimmu.2024.1396122. eCollection 2024. Front Immunol. 2024. PMID: 38817601 Free PMC article. Review.
Cited by
-
Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.Int J Clin Oncol. 2021 Sep;26(9):1752-1758. doi: 10.1007/s10147-021-01951-7. Epub 2021 Jun 6. Int J Clin Oncol. 2021. PMID: 34091796
-
Hormonal regulation of hematopoietic stem cells and their niche: a focus on estrogen.Int J Stem Cells. 2015 May;8(1):18-23. doi: 10.15283/ijsc.2015.8.1.18. Int J Stem Cells. 2015. PMID: 26019751 Free PMC article. Review.
-
Primary chronic osteomyelitis of the jaw - a descriptive study of the condition and its occurrence in Sweden between 2012 and 2018.Acta Odontol Scand. 2024 Sep 25;83:531-536. doi: 10.2340/aos.v83.41989. Acta Odontol Scand. 2024. PMID: 39319674 Free PMC article.
-
l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways.J Cell Mol Med. 2020 Jan;24(1):785-798. doi: 10.1111/jcmm.14790. Epub 2019 Nov 14. J Cell Mol Med. 2020. PMID: 31725199 Free PMC article.
-
EFFECT OF ORAL CONTRACEPTIVES ON BONE MINERAL DENSITY.Acta Endocrinol (Buchar). 2022 Jul-Sep;18(3):355-360. doi: 10.4183/aeb.2022.355. Acta Endocrinol (Buchar). 2022. PMID: 36699167 Free PMC article. Review.
References
-
- Albright F. Post-menopausal osteoporosis. Trans Assoc Am Physicians. 1940;55:298–305.
-
- Lindsay R, Aitkin JM, Anderson JB, Hart DM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet i. 1976:1038–1040. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous